Morgan Stanley posted first quarter earnings that surpassed analysts’ expectations.
The bank’s earnings came in $2.02 per share in the quarter, well above the $1.68 expected by analysts polled by Refinitiv.
Revenue of $14.8 billion also surpassed the $14.2 billion expected.
Revenue at Morgan Stanley’s equity trading desk was $3.2 billion for the quarter, higher than an expectation of $2.7 billion, according to StreetAccount. Fixed-income revenue of $2.9 billion exceeded expectations of $2.2 billion from StreetAccount.
The company’s wealth management revenue came in at $5.9 billion, flattish year-over-year, and lower than the $6.2 billion expected by analysts polled by StreetAccount.
Investment banking revenue was $1.6 billion, - 37% lower from the year-ago quarter, and also from lower than the $1.8 billion estimate according to StreetAccount. A significant decrease in equity underwriting revenues led to the disappointing figure, the bank indicated.
MS saw its Momentum Indicator move above the 0 level on December 01, 2023. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 73 similar instances where the indicator turned positive. In of the 73 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for MS just turned positive on November 02, 2023. Looking at past instances where MS's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .
MS moved above its 50-day moving average on November 29, 2023 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MS crossed bullishly above the 50-day moving average on November 22, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MS advanced for three days, in of 325 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 301 cases where MS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for MS moved out of overbought territory on November 20, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.395) is normal, around the industry mean (4.711). P/E Ratio (13.736) is within average values for comparable stocks, (32.620). Projected Growth (PEG Ratio) (2.635) is also within normal values, averaging (2.400). Dividend Yield (0.042) settles around the average of (0.037) among similar stocks. P/S Ratio (2.524) is also within normal values, averaging (99.483).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of diversified financial services including brokerage, investment management and venture capital services
A.I.dvisor indicates that over the last year, MS has been closely correlated with SF. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if MS jumps, then SF could also see price increases.